Literature DB >> 15191166

Intracerebral xenotransplantation of GFP mouse bone marrow stromal cells in intact and stroke rat brain: graft survival and immunologic response.

H Irons1, J G Lind, C G Wakade, G Yu, M Hadman, J Carroll, D C Hess, C V Borlongan.   

Abstract

The present study characterized survival and immunologic response of bone marrow stromal cells (BMSCs) following transplantation into intact and stroke brains. In the first study, intrastriatal transplantation of BMSC (60,000 in 3 microl) or vehicle was performed in normal adult Sprague-Dawley male rats that subsequently received daily cyclosporin A (CsA, 10 mg/kg, IP in 3 ml) or vehicle (olive oil, similar volume) starting on day of surgery up to 3 days posttransplantation. Animals were euthanized at 3 or 30 days posttransplantation and brains were processed either for green fluorescent protein (GFP) microscopy or flow cytometry (FACS). Both GFP epifluorescence and FACS scanning revealed GFP+ BMSCs in both groups of transplanted rats with or without CsA, although significantly increased (1.6- to 3-fold more) survival of GFP+ BMSCs was observed in the immunosuppressed animals. Further histologic examination revealed widespread dispersal of BMSCs away from the graft core accompanied by many long outgrowth processes in non-CsA-transplanted animals, whereas a very dense graft core, with cells expressing only sporadic short outgrowth processes, was observed in CsA-transplanted animals. There were no detectable GFP+ BMSCs in nontransplanted rats that received CsA or vehicle. Immunologic response via FACS analysis revealed a decreased presence of cytotoxic cells, characterized by near complete absence of CD8+ cells, and lack of activation depicted by low CD69 expression in CsA-treated transplanted animals. In contrast, elevated levels of CD8+ cells and increased activation of CD69 expression were observed in transplanted animals that received vehicle alone. CD4+ helper cells were almost nondetectable in transplanted rats that received CsA, but also only minimally elevated in transplanted rats that received vehicle. Nontransplanted rats that received either CsA or vehicle displayed very minimal detectable levels of all three lymphocyte markers. In the second study, a new set of male Sprague-Dawley rats initially received bilateral stereotaxic intrastriatal transplantation of BMSCs and 3 days after were subjected to unilateral transient occlusion of middle cerebral artery. The animals were allowed to survive for 3 days after stroke without CsA immunosuppression. Epifluorescence microscopy revealed significantly higher (5-fold more) survival of transplanted GFP+ BMSCs in the stroke striatum compared with the intact striatum. The majority of the grafts remained within the original dorsal striatal transplant site, characterized by no obvious migration in intact striatum, but with long-distance migration along the ischemic penumbra in the stroke striatum. Moreover, FACS scanning analyses revealed low levels of immunologic response of grafted BMSCs in both stroke and intact striata. These results, taken together, suggest that xenotransplantation of mouse BMSCs into adult rats is feasible. Immunosuppression therapy can enhance xenograft survival and reduce graft-induced immunologic response; however, in the acute phase posttransplantation, BMSCs can survive in intact and stroke brain, and may even exhibit long-distance migration and increased outgrowth processes without immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15191166     DOI: 10.3727/000000004783983990

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  13 in total

1.  Trophic factor induction of human umbilical cord blood cells in vitro and in vivo.

Authors:  Ning Chen; Siddharth Kamath; Jennifer Newcomb; Jennifer Hudson; Svitlana Garbuzova-Davis; Paula Bickford; Cyndy Davis-Sanberg; Paul Sanberg; Tanja Zigova; Alison Willing
Journal:  J Neural Eng       Date:  2007-04-04       Impact factor: 5.379

2.  Transplants of human mesenchymal stem cells improve functional recovery after spinal cord injury in the rat.

Authors:  Dasa Cízková; Ján Rosocha; Ivo Vanický; Stanislava Jergová; Milan Cízek
Journal:  Cell Mol Neurobiol       Date:  2006-07-29       Impact factor: 5.046

Review 3.  Baby STEPS: a giant leap for cell therapy in neonatal brain injury.

Authors:  Cesar V Borlongan; Michael D Weiss
Journal:  Pediatr Res       Date:  2011-07       Impact factor: 3.756

4.  Long-term magnetic resonance imaging of stem cells in neonatal ischemic injury.

Authors:  Andre Obenaus; Nejmi Dilmac; Beatriz Tone; Hou Rou Tian; Richard Hartman; Murat Digicaylioglu; Evan Y Snyder; Stephen Ashwal
Journal:  Ann Neurol       Date:  2010-11-22       Impact factor: 10.422

Review 5.  Bone marrow stromal cells as a therapeutic treatment for ischemic stroke.

Authors:  Zizhen Yang; Lei Zhu; Fangqin Li; Jing Wang; Huan Wan; Yujun Pan
Journal:  Neurosci Bull       Date:  2014-05-10       Impact factor: 5.203

6.  Experimental study on trace marking and oncogenicity of neural stem cells derived from bone marrow.

Authors:  Xiaodan Jiang; Ruxiang Xu; Zhijun Yang; Peng Jin; Qiang Xu; Gang Li; Wei Wang; Keli Liao; Xiaoqiu Liu; Yiquan Ke; Shizhong Zhang; Mouxuan Du; Yuxi Zou; Yingqian Cai; Yanjun Zeng
Journal:  Cell Mol Neurobiol       Date:  2007-09-05       Impact factor: 5.046

7.  Axonal sprouting into the denervated spinal cord and synaptic and postsynaptic protein expression in the spinal cord after transplantation of bone marrow stromal cell in stroke rats.

Authors:  Zhongwu Liu; Yi Li; Runjiang Qu; Lihong Shen; Qi Gao; Xueguo Zhang; Mei Lu; Smita Savant-Bhonsale; Jade Borneman; Michael Chopp
Journal:  Brain Res       Date:  2007-02-27       Impact factor: 3.252

Review 8.  The role of astrocytes in mediating exogenous cell-based restorative therapy for stroke.

Authors:  Yi Li; Zhongwu Liu; Hongqi Xin; Michael Chopp
Journal:  Glia       Date:  2013-11-04       Impact factor: 7.452

9.  Cellular immune response to intrastriatally implanted allogeneic bone marrow stromal cells in a rat model of Parkinson's disease.

Authors:  Dianne M Camp; David A Loeffler; Diane M Farrah; Jade N Borneman; Peter A LeWitt
Journal:  J Neuroinflammation       Date:  2009-06-05       Impact factor: 8.322

10.  TSP-1 secreted by bone marrow stromal cells contributes to retinal ganglion cell neurite outgrowth and survival.

Authors:  Keming Yu; Jian Ge; James Bradley Summers; Fan Li; Xuan Liu; Ping Ma; Joseph Kaminski; Jing Zhuang
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.